Tecan Group AG (LON:0QLN)

Market Cap	1.92B
Revenue (ttm)	823.54M
Net Income (ttm)	59.64M
Shares Out	n/a
EPS (ttm)	4.66
PE Ratio	32.18
Forward PE	20.94
Dividend	2.79 (1.71%)
Ex-Dividend Date	Apr 14, 2025

Volume	300
Average Volume	7,297
Open	164.30
Previous Close	163.50
Day's Range	160.80 - 164.30
52-Week Range	134.30 - 335.80
Beta	0.96
RSI	48.59
Earnings Date	Aug 12, 2025

About Splunk

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized O...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1980
• Employees: 3,341
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QLN

Financial Performance

In 2024, Tecan Group AG's revenue was 934.28 million, a decrease of -13.04% compared to the previous year's 1.07 billion. Earnings were 67.66 million, a decrease of -48.77%.